Tazemetostat
Showing 1 - 25 of 49
T-cell Lymphoma, CLL/SLL Trial in Birmingham (Tazemetostat, Acalabrutinib and Tazemetostat)
Not yet recruiting
- T-cell Lymphoma
- CLL/SLL
- Tazemetostat
- Acalabrutinib and Tazemetostat
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 11, 2023
Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)
Not yet recruiting
- Follicular Lymphoma
- Mosunetuzumab
- Tazemetostat Pill
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Aug 8, 2023
Follicular Lymphoma, Refractory Follicular Lymphoma Trial (Tazverik (Tazemetostat))
Not yet recruiting
- Follicular Lymphoma
- Refractory Follicular Lymphoma
- Tazverik (Tazemetostat)
- (no location specified)
Oct 6, 2023
Peripheral Nerve Sheath Tumor Trial in Gainesville (Tazemetostat)
Recruiting
- Peripheral Nerve Sheath Tumor
- Tazemetostat
-
Gainesville, FloridaUniversity of Florida
Jan 4, 2023
Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)
Not yet recruiting
- Follicular Lymphoma
- +3 more
- Tazemetostat Pill
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023
Relapsed/Refractory Lymphoma Trial in Shanghai (tazemetostat, HMPL-689)
Not yet recruiting
- Relapsed/Refractory Lymphoma
- tazemetostat
- HMPL-689
-
Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Feb 2, 2023
Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)
Suspended
- Solid Tumor
- ARID1A Gene Mutation
- Tazemetostat
-
Greenville, South CarolinaPrisma Health Cancer Institute
Jan 10, 2023
Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Venetoclax
- Tazemetostat
-
New York, New YorkWeill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023
Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)
Not yet recruiting
- Relapsed Follicular Lymphoma
- Refractory Follicular Lymphoma
- TAZEMETOSTAT
- Zandelisib
-
Boston, Massachusetts
- +1 more
Oct 28, 2022
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Isehara, Chuo-ku (tazemetostat)
Completed
- Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
- Tazemetostat
-
Isehara, Kanagawa, Japan
- +1 more
Apr 6, 2022
Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Tazemetostat, Pembrolizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Tazemetostat
- Pembrolizumab
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Recurrent DLBCL Germinal Center B-Cell Type, Recurrent Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma Trial (Belinostat,
Not yet recruiting
- Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
- +5 more
- Belinostat
- +2 more
- (no location specified)
Dec 2, 2022
Relapsed/Refractory Follicular Lymphoma With EZH2 Trial in Shanghai (Tazemetostat)
Not yet recruiting
- Relapsed/Refractory Follicular Lymphoma With EZH2
- Tazemetostat
-
Shanghai, Shanghai, ChinaShanghai Cancer Center
Jul 20, 2022
Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant
Recruiting
- Atypical Teratoid Rhabdoid Tumor
- +6 more
- Tazemetostat
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 23, 2023
Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)
Recruiting
- Metastatic Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- Talazoparib
- Tazemetostat
-
Boston, Massachusetts
- +1 more
Jul 18, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Metastatic Melanoma
- Dabrafenib Mesylate
- +2 more
-
Atlanta, Georgia
- +6 more
Nov 30, 2022
Prostate Cancer Trial in Los Angeles (Tazverik)
Not yet recruiting
- Prostate Cancer
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Sep 30, 2022
Non Small Cell Lung Cancer Trial in West Los Angeles (Tazemetostat)
Not yet recruiting
- Non Small Cell Lung Cancer
- Tazemetostat
-
West Los Angeles, CaliforniaVA Greater Los Angeles Healthcare System, West Los Angeles, CA
Jul 21, 2022
Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +3 more
- Biopsy
- +4 more
-
Los Angeles, California
- +8 more
Jan 31, 2023
Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Duarte (Tazemetostat, Ublituximab, Umbralisib)
Not yet recruiting
- Recurrent Follicular Lymphoma
- Refractory Follicular Lymphoma
- Tazemetostat
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 31, 2022
Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)
Temporarily not available
- Epithelioid Sarcoma (Ex-US Only)
- +19 more
- Tazemetostat
- (no location specified)
Oct 17, 2022
Relapsed/Refractory Trial in Santa Fe (Tafasitamab, Lenalidomide, Tazemetostat)
Recruiting
- Relapsed/Refractory
- Tafasitamab
- +8 more
-
Santa Fe, CaliforniaCalifornia Cancer Associates For Research And Excellence, cCARE
Feb 23, 2022
COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome Trial (Tazemetostat)
Withdrawn
- COVID-19 Acute Respiratory Distress Syndrome
- Cytokine Release Syndrome
- Tazemetostat
- (no location specified)
Nov 17, 2021